Jan 15, 2026 by Adé HennisSprinklr. Inc Director Sprinkles Some Additional Shares in Her PortfolioA director of a top enterprise cloud company exercised stock options to close out 2025. And just like cloud storage, she decided to store some shares away.
Jan 15, 2026 by Adé HennisGLDM vs. SLV: The Precious Metal ETFs That Just Had Historic Annual ReturnsThese two precious metal ETFs just logged their biggest yearly gains ever. But how do these metal monoliths stack up against each other?
Jan 15, 2026 by Adé HennisThe Andersons' Director Conducts Multiple Sales to Close 2025This agricultural and nutrient leader has seen its stock grow just like its crops, but its director is chopping thousands of insider shares from his portfolio through multiple transactions.
Jan 15, 2026 by Adé HennisBrady Corporation President Sold Shares Towards the End of 2025After months of consistent price gains, a President at Brady Corporation sold shares in December 2025.
Jan 14, 2026 by Adé HennisAxogen CEO Axed 25,000 Shares From His Direct HoldingsThe CEO of this innovative nerve regeneration company sold thousands of shares in December 2025, among multiple other insiders at the company who sold shares to close out that year.
Jan 14, 2026 by Adé HennisThis ePlus Director Dumped Shares Multiple Times In Late 2025A director at one of the top IT solutions companies sold shares in late 2025 amid the stock having a strong year of performance.
Jan 14, 2026 by Adé HennisSentinelOne CEO Sold 125K Insider Shares for $1.9 Million in Mid-December The CEO of a top AI-powered cybersecurity provider reported a significant insider sale.
Jan 14, 2026 by Adé HennisCollegium Pharmaceutical EVP Sells COLL 17,600 Shares Amid Strong Close of 2025An executive vice president at a top pharmaceutical company sold shares towards the end of 2025, while the company's shares reached record numbers that year.
Jan 14, 2026 by Adé HennisLife360 Director Sells Shares Amid Strong 2025 PerformanceKnown for helping families stay in the right place, this tech firm’s director sold insider shares toward the end of 2025 despite the company’s stock strongly finding its place in the market.
Jan 13, 2026 by Adé HennisA 10% Owner Of Structure Therapeutics Shed SharesA company controlled by the Johnson family sold thousands of shares of this clinical-stage biopharmaceutical company, but that hasn't stopped the pharmaceutical stock from surging.
Jan 13, 2026 by Adé HennisLive Oak Bancshares CEO Lobbed Up 10,000 Shares For Sale in DecemberThe CEO of this top banking and fintech company sold 10,000 shares in December, which coincided with a period of underwhelming stock performance.
Jan 13, 2026 by Adé HennisBiglari Holdings CEO Purchases Over 2,000 Insider SharesThe CEO of this diversified restaurant franchise holding company is buying shares like hot cakes, all while the stock has been sizzling.
Jan 13, 2026 by Adé HennisGlobal Partners LP Insider Purchases Nearly 4000 Shares To Close Out 2025A general partner of a top fuel distributor and retailer Global Partners LP reported a recent insider buy amid a year of price decline for the first time in years.
Jan 12, 2026 by Adé HennisSionna Therapeutics Chief Legal Officer Caps Off Strong 2025 with Sale of Over 10,000 SharesAfter having a successful IPO less than a year ago, this biotech innovator had notable insider transactions to close out 2025.
Jan 12, 2026 by Adé HennisUrban Outfitters Co-President Sell Shares For $14 Million Amid Record YearThis top retailer had one of the best-performing years in 2025, and the company's top two insiders are capitalizing on the stock's strong performance.
Jan 12, 2026 by Adé HennisFirst Hawaiian Bank Board Member Says Aloha to $1 Million With Recent Insider SalesThis leading Hawaii-based bank, with a strong dividend track record, has just reported significant insider selling by one of its top board members.
Jan 12, 2026 by Adé HennisUWMC CEO Sells Millions of Insider SharesThe CEO of one of America's biggest mortgage lenders has been selling millions of his shares within the past month, generating huge profits within such a short time.
Jan 12, 2026 by Adé HennisCelldex Therapeutics SVPs Engage In Heavy TransactionsMultiple Senior Vice Presidents of this biotech company recently engaged in transactions that involved thousands of shares. What does this mean for the stock as it continues its long journey to regain price value?
Jan 11, 2026 by Adé HennisVNQI vs. REET: How Does Vanguard's Fund Compare Against the Largest Global Real Estate ETF?Vanguard is recognized for managing some of the world's top real estate ETFs. But does one of its ETFs compare to the largest global real estate ETF?
Jan 10, 2026 by Adé HennisGQRE vs. REET: The Rising ETF Against the Largest Global Real Estate ETFThis real estate ETF uses strict criteria to maximize quality assets, but is it good enough to match up against the world's largest global real estate ETF?